Deconstructing the 2023 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Pseudomonas aeruginosa

Clin Infect Dis. 2023 May 24;76(10):1868-1870. doi: 10.1093/cid/ciad012.

¹ Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
² Faculty of Medicine, UQ Center for Clinical Research, Royal Brisbane and Women's Hospital Campus, University of Queensland, Brisbane, Australia.
³ Department of Medicine and Pathology, University of Virginia, Charlottesville, Virginia, USA.
⁴ Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.
⁵ Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

No abstract available

Publication types